ROSPA - Record on Satisfaction of Patients With Actonel 35 mg Once a Week
To determine the satisfaction of subject with Actonel 35 mg Once a Week in the treatment of post-menopausal osteoporosis. Open, non-controlled, multi-center study...
Brief Summary
Official Title: “Record on Satisfaction of Patients With Actonel 35 mg Once a Week”
To determine the satisfaction of subject with Actonel 35 mg Once a Week in the treatment of post-menopausal osteoporosis. Open, non-controlled, multi-center study.
- Study Type: Interventional
- Study Design: Allocation: Non-Randomized, Endpoint Classification: Safety Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment
- Study Primary Completion Date: September 2006
Intervention(s) in this Clinical Trial
- Drug: Risedronate
Outcome Measures for this Clinical Trial
Primary Measures
- Patient satisfaction and compliance
- Time Frame: During all the study
Safety Issue?: No
- Time Frame: During all the study
Criteria for Participation in this Clinical Trial
Inclusion criteria :
- Postmenopausal ambulatory women
- Established osteoporosis
Exclusion criteria:
- History of cancer: basal cell or squamous cell carcinoma-documented 6-month remission,
- Diagnosis of hypocalcemia, hyperparathyroidism, hyperthyroidism
- The above information is not intended to contain all considerations relevant to a patient's potential participation in a clinical trial.
Gender Eligibility for this Clinical Trial: Female
Minimum Age for this Clinical Trial: 55 Years
Maximum Age for this Clinical Trial: 80 Years
Are Healthy Volunteers Accepted for this Clinical Trial?: No
Clinical Trial Investigator Information
Lead Investigator: Sanofi-Aventis Industry
Overall Clinical Trial Officials and Contacts
Jean-Marc Chantelot, MD Study Director Sanofi-Aventis
Additional Information
Information obtained from ClinicalTrials.gov on February 12, 2012
Link to the current ClinicalTrials.gov record. http://clinicaltrials.gov/show/NCT00544180
Study ID Number: RISED_L_01686
ClinicalTrials.gov Identifier: NCT00544180
Health Authority: Israel: Ministry of Health
Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.
The URL of this page is:
http://clinicaltrialsfeeds.org/clinical-trials/show/NCT00544180
